Skip to content
2000
Volume 14, Issue 6
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background: Nicotinamide adenine dinucleotide (NAD) is an essential coenzyme that plays crucial roles in energy metabolism, DNA repair and cell death. Due to the high proliferation rate and the high energy necessity in cancer cells, NAD biosynthesis and salvage is required. Owing to the NAD importance in cancer cells, NAD salvage/recycling enzymes are targets for drug discovery. Methods: Herein we focused on NMNAT is a housekeeping enzyme in all organisms catalyzing coupling of ATP and NMN or NaMN yielding NAD or NaAD, respectively. In mammals, three NMNAT isoforms, nuclear NMNAT1, cytoplasmic NMNAT2 and mitochondrial NMNAT3 have been identified. Results: As there is no crystal structure for hNMNAT2, 3D structure models were built based on hNMNAT1 (42% identity) and hNMNAT3 (41.5% identity). To date, only a few hNMNAT inhibitors have been reported so far in the literature: Gallotannin, some NAD analogues and aminophenylsulfonamide derivatives. With the aim of investigating the differences in isoenzyme structures and catalytic properties in molecular level, molecular docking studies of compounds 1-5 were performed. Conclusion: Finally, this study might be helpful for the development of inhibitors potentially useful as new chemotherapeutics targeting NMNATs.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180814666161110112859
2017-01-01
2025-09-05
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180814666161110112859
Loading

  • Article Type:
    Research Article
Keyword(s): Gallotannin; Homology modeling; isoenzyme; molecular docking; NaMNAT; NMNAT
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test